Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

DEST.L (DEST) Regulatory News

Date Source Headline
10th Sep 2019 7:00 am RNS University of Sheffield Research Collaboration
2nd Sep 2019 7:00 am RNS XF Drug platform data presented at EuroBiofilms
15th Aug 2019 12:20 pm RNS Holding(s) in Company
31st Jul 2019 7:00 am RNS Presentation at Gordon Research Conference
19th Jul 2019 3:12 pm RNS Holding(s) in Company
4th Jun 2019 2:39 pm RNS Grant of Options
4th Jun 2019 12:06 pm RNS Result of AGM
9th May 2019 2:06 pm RNS Appointment of NOMAD and Joint Broker
29th Apr 2019 2:28 pm RNS Posting of Annual Report and Notice of AGM
9th Apr 2019 7:00 am RNS Final Results
5th Apr 2019 5:06 pm RNS Exercise of Options
1st Apr 2019 3:03 pm RNS Exercise of Options
28th Mar 2019 6:13 pm RNS Exercise of Options
27th Mar 2019 7:00 am RNS MedPharm to develop new XF-drug formulations
22nd Mar 2019 9:47 am RNS Notice of Results
6th Mar 2019 6:00 pm RNS Exercise of Options
28th Jan 2019 7:00 am RNS Second positive phase 1 trial data for XF-73
25th Jan 2019 7:00 am RNS New grant awarded under UK-China AMR programme
24th Jan 2019 11:50 am RNS Destiny Pharma notes UK 5-year action plan on AMR
1st Nov 2018 7:00 am RNS Research collaboration with Southampton University
25th Oct 2018 4:05 pm RNS Grant of Options
25th Oct 2018 7:00 am RNS Directorate Change
24th Oct 2018 7:00 am RNS UK government highlights global threat of AMR
19th Oct 2018 7:00 am RNS BIA celebrates UK bioscience innovative
26th Sep 2018 7:00 am RNS Dr Jesús González appointed Chief Medical Officer
26th Sep 2018 7:00 am RNS Interim results for six months ended 30 June 2018
6th Sep 2018 7:00 am RNS Directorate Change
26th Jul 2018 7:00 am RNS Positive Phase 1 skin irritation study with XF-73
17th Jul 2018 7:00 am RNS Research collaboration with Aston University
11th Jul 2018 7:00 am RNS Notice of Results
21st Jun 2018 7:00 am RNS Directorate Change
14th Jun 2018 7:00 am RNS Destiny Pharma notes FDA statement on AMR focus
5th Jun 2018 12:47 pm RNS Director/PDMR Shareholding
31st May 2018 12:30 pm RNS Result of AGM
30th May 2018 7:00 am RNS Destiny Establishes Scientific Advisory Board
23rd Apr 2018 7:00 am RNS Posting of Annual Report and Notice of AGM
12th Apr 2018 7:00 am RNS Destiny Pharma announces clinical update on XF-73
12th Apr 2018 7:00 am RNS Final Results
23rd Mar 2018 7:00 am RNS Notice of Full Year Results
22nd Mar 2018 7:00 am RNS Appointment of Joint Broker
FTSE 100 Latest
Value8,809.74
Change53.53